Corgi FundsLeveraged EquityXBIX · Cboe BZX

Corgi U.S. Biotech 2x Daily ETF (XBIX)

Compare Leveraged & Inverse ETFs Compare with others

Price: $34.66; —25 Sept 2026
Assets: $580,000; Total net assets
Expense ratio: 0.45%; Category 0.00%
Yield: —; Trailing distributions

1Y return: —; Category 30.7%
3Y CAGR: —; Category 28.8%
5Y CAGR: —; Category 5.3%

Loading NAV history…

Corgi U.S. Biotech 2x Daily ETF

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily closes. Risk-free rate 4% a year.

Standard deviation: —
Maximum drawdown: —
Sharpe ratio: —
Sortino ratio: —
Beta: —
Alpha: —
R²: —
Information ratio: —
Upside capture: —
Downside capture: —
Tracking error: —

Trailing returns compared with benchmark
Period	1M	3M	6M	YTD	1Y	3YCAGR	5YCAGR	10YCAGR	LaunchCAGR
ETF	-16.5%	-5.0%	—	—	—	—	—	—	+34.2%
Leveraged Equity average	2.1%	3.2%	48.8%	19.9%	30.7%	28.8%	5.3%	8.3%	-0.2%
Difference	-18.6%	-8.1%	—	—	—	—	—	—	+34.5%

Holdings

The 1 largest positions make up 11.1% of the fund.

Top holdings

Largest holdings by weight
Ticker	Holding	Weight
FGXXX	First American Government Obligs X	11.06%

Asset mix

What the fund is invested in.

Stocks199.3%
Other2.9%

ETF details

Issuer: Corgi Funds
Category: Equity · Leveraged Equity
Ticker: XBIX
Exchange: Cboe BZX
Inception: 2 Jun 2026 (0.3 years)
Structure: Exchange Traded Fund
Expense ratio: 0.45% (category 0.00%)
Holdings turnover: 0%
Distribution yield: —
Beta, 3 years: 0.00
Total net assets: $580,000

Prices and returns as of 25 Sept 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.

Other leveraged equity ETFs

Other ETFs in the Leveraged Equity category.

Compare Leveraged & Inverse ETFs